Table 1.
Group | AP (mg I ml−1) | PVP (mg I ml−1) | ||||
Residual tumour | Periablational reactive tissue | p-value | Residual tumour | Periablational reactive tissue | p-value | |
3-day (n=6) | 1.83±0.21 | 1.85±0.36 | 0.876 | 1.68±0.18 | 1.75±0.14 | 0.286 |
1-week (n=6) | 1.73±0.21 | 1.57±0.43 | 0.175 | 1.60±0.42 | 1.68±0.48 | 0.698 |
2-week (n=6) | 1.72±0.27 | 1.18±0.20 | <0.01 | 1.60±0.30 | 1.53±0.49 | 0.781 |
3-week (n=6) | 1.70±0.14 | 0.95±0.19 | <0.01 | 1.60±0.14 | 1.22±0.15 | <0.01 |
AP, arterial phase; PVP, portal venous phase.